United States · Funded startup
3 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Follow Denali Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$547Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
From a historical funding record
From the SEC filings it signed: 3 on the team.
On the board, as filediDavid P. SchenkeinErik T. HarrisJay T. FlatleyJennifer O. CookMarc P. Tessier-LavigneNancy A. ThornberryPeter S. KleinSteve E. KrognesVicki L. Sato
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
These 2 firms list Denali Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Denali Therapeutics's investors include ARCH Venture Partners, Google Ventures, Eight Roads Ventures, F-Prime Capital and Baillie Gifford, and 3 more on record.
Denali Therapeutics has raised $547M across 3 rounds since 2015.
Denali Therapeutics's most recent round was a Debt of $200M in Dec 2025.
Denali Therapeutics's largest round on record is $217M (Series A), in May 2015.
Denali Therapeutics's first round on record, in May 2015, was backed by ARCH Venture Partners, F-Prime Capital and Flagship Ventures and 1 others.
Denali Therapeutics's latest named round is a Debt, in Dec 2025.
Denali Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
